Insider Ledger
CADL insider buying and SEC filings, explained
Candel Therapeutics, Inc. · CIK 1841387
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$3.0M
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$3.6M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 10–11, 2026 | Planned (10b5-1) | Paul Peter Tak (CEO and Director) sold 280,245 shares between Sep 10 and Sep 11 at about $11.28 ($3.2M), marked as a 10b5-1 plan trade. Holdings down 71% to 113,321 shares. | SEC filing Filed Sep 11, 2026 |
| Aug 17, 2026 | Planned (10b5-1) | Seshu Tyagarajan (Chief Technology Officer) sold 7,000 shares at $12.00 ($84K), marked as a 10b5-1 plan trade. Holdings down 8% to 76,865 shares. | SEC filing Filed Aug 19, 2026 |
| Jun 29, 2026 | Planned (10b5-1) | Seshu Tyagarajan (Chief Technology Officer) sold 7,000 shares at about $10.02 ($70K), marked as a 10b5-1 plan trade. Holdings down 8% to 83,865 shares. | SEC filing Filed Jul 1, 2026 |
| Jun 29, 2026 | Planned (10b5-1) | Francesca Barone (Chief Scientific Officer) sold 23,447 shares at about $10.06 ($236K), marked as a 10b5-1 plan trade. Holdings down 23% to 77,362 shares. | SEC filing Filed Jul 1, 2026 |
| Feb 23, 2026 | Purchase (code P) | Paul B Manning (Director) bought 550,458 shares indirectly (by trust) at $5.45 ($3.0M), reported as a purchase (code P). Holdings by trust up 25% to 2,763,527 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 26, 2026 |
26 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow CADL in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.